82 FR 35546 - Importer of Controlled Substances Application: R & D Systems, Inc.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 82, Issue 145 (July 31, 2017)
Drug Enforcement Administration
Federal Register Volume 82, Issue 145 (July 31, 2017)
| Page Range | 35546-35547 | |
| FR Document | 2017-16064 |
[Federal Register Volume 82, Number 145 (Monday, July 31, 2017)] [Notices] [Pages 35546-35547] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-16064] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Importer of Controlled Substances Application: R & D Systems, Inc. ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before August 30, 2017. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before August 30, 2017. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 [[Page 35547]] Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on March 7, 2017, R & D Systems, Inc., Bio-Techne, 614 McKinley Place NE., Minneapolis, Minnesota 55413 applied to be registered as an importer of the following basic classes of controlled substances: ------------------------------------------------------------------------ Controlled substance Drug code Schedule ------------------------------------------------------------------------ Mephedrone (4-Methyl-N- 1248 I methylcathinone). JWH-018 (also known as AM678) (1- 7118 I Pentyl-3-(1-naphthoyl)indole). CP-47,497 (5-(1,1-Dimethylheptyl)-2- 7297 I [(1R,3S)-3-hydroxycyclohexyl- phenol). Marihuana.......................... 7360 I Tetrahydrocannabinols.............. 7370 I 4-Bromo-2,5-dimethoxyamphetamine... 7391 I 3,4-Methylenedioxymethamphetamine.. 7405 I Dimethyltryptamine................. 7435 I Psilocyn........................... 7438 I Pentobarbital...................... 2270 II Phencyclidine...................... 7471 II Cocaine............................ 9041 II ------------------------------------------------------------------------ The company plans to import bulk active pharmaceutical controlled substances for distribution to its customers for analytical purposes. In reference to drug codes 7360 and 7370, the company plans to import a synthetic cannabidiol and a synthetic tetrahydrocannabinol. No other activity for these drug codes is authorized for this registration. Dated: July 24, 2017. Demetra Ashley, Acting Assistant Administrator. [FR Doc. 2017-16064 Filed 7-28-17; 8:45 am] BILLING CODE 4410-09-P
![35546 Federal Register / Vol. 82, No. 145 / Monday, July 31, 2017 / Notices
personal identifying information in your filed for the purpose of extending the DATES: Registered bulk manufacturers of
comment, you should be aware that Act’s provisions limiting the recovery of the affected basic classes, and
your entire comment, including your antitrust plaintiffs to actual damages applicants therefore, may file written
personal identifying information, may under specified circumstances. comments on or objections to the
be made publicly available at any time. Specifically, Chrysler Group, LLC, issuance of the proposed registration in
While you can ask us in your comment Auburn Hills, MI, and Mercedes-Benz accordance with 21 CFR 1301.33(a) on
to withhold your personal identifying Research & Development North or before September 29, 2017.
information from public review, we America, Inc., Sunnyvale, CA, have
ADDRESSES: Written comments should
cannot guarantee that we will be able to withdrawn as a parties to this venture.
be sent to: Drug Enforcement
do so. No other changes have been made in
Administration, Attention: DEA Federal
Authority: The authorities for this action either the membership or planned
Register Representative/DRW, 8701
are the Surface Mining Control and activity of the group research project.
Morrissette Drive, Springfield, Virginia
Reclamation Act of 1977, as amended (30 Membership in this group research
U.S.C. 1201 et seq.), and the Paperwork 22152.
project remains open, and V2I
Reduction Act of 1995 (44 U.S.C. 3501 et Consortium intends to file additional SUPPLEMENTARY INFORMATION: The
seq.). written notifications disclosing all Attorney General has delegated his
Dated: June 15, 2017. changes in membership. authority under the Controlled
John A. Trelease, On December 3, 2014, V2I Consortium Substances Act to the Administrator of
Acting Chief, Division of Regulatory Support. filed its original notification pursuant to the Drug Enforcement Administration
[FR Doc. 2017–16044 Filed 7–28–17; 8:45 am] Section 6(a) of the Act. The Department (DEA), 28 CFR 0.100(b). Authority to
BILLING CODE 4310–05–P of Justice published a notice in the exercise all necessary functions with
Federal Register pursuant to Section respect to the promulgation and
6(b) of the Act on December 31, 2014 implementation of 21 CFR part 1301,
DEPARTMENT OF JUSTICE (79 FR 78908). incident to the registration of
Patricia A. Brink, manufacturers, distributors, dispensers,
Antitrust Division importers, and exporters of controlled
Director of Civil Enforcement, Antitrust
Division. substances (other than final orders in
Notice Pursuant to the National connection with suspension, denial, or
Cooper, Ative Research and [FR Doc. 2017–16050 Filed 7–28–17; 8:45 am]
revocation of registration) has been
Production Act of 1993—Vehicle To BILLING CODE P
redelegated to the Assistant
Infrastructure Consortium Administrator of the DEA Diversion
Notice is hereby given that, on June DEPARTMENT OF JUSTICE Control Division (‘‘Assistant
29, 2017, pursuant to Section 6(a) of the Administrator’’) pursuant to section 7 of
National Cooperative Research and Drug Enforcement Administration 28 CFR part 0, appendix to subpart R.
Production Act of 1993, 15 U.S.C. 4301 In accordance with 21 CFR
et seq. (‘‘the Act’’), Vehicle to [Docket No. DEA–392] 1301.33(a), this is notice that on May 17,
Infrastructure Consortium (‘‘V2I 2017, Isosciences, LLC, 1017 West 9th
Consortium’’) has filed written Bulk Manufacturer of Controlled Avenue, Building 10, Suite B, King of
notifications simultaneously with the Substances Application: Isosciences, Prussia, Pennsylvania 19406 applied to
Attorney General and the Federal Trade LLC be registered as a bulk manufacturer of
Commission disclosing changes in its the following basic classes of controlled
ACTION: Notice of application.
membership. The notifications were substances:
Controlled substance Drug code Schedule
Cathinone ........................................................................................................................................................................ 1235 I
Methcathinone ................................................................................................................................................................. 1237 I
Lysergic acid diethylamide .............................................................................................................................................. 7315 I
3,4-Methylenedioxyamphetamine .................................................................................................................................... 7400 I
3,4-Methylenedioxy-N-ethylamphetamine ....................................................................................................................... 7404 I
Amphetamine ................................................................................................................................................................... 1100 II
Methamphetamine ........................................................................................................................................................... 1105 II
Codeine ........................................................................................................................................................................... 9050 II
Morphine .......................................................................................................................................................................... 9300 II
The company plans to manufacture DEPARTMENT OF JUSTICE comments on or objections to the
small quantities of the listed controlled issuance of the proposed registration in
substances to make reference standards Drug Enforcement Administration accordance with 21 CFR 1301.34(a) on
which will be distributed to their [Docket No. DEA–392] or before August 30, 2017. Such persons
customers. may also file a written request for a
sradovich on DSKBCFCHB2PROD with NOTICES
Dated: July 24, 2017. Importer of Controlled Substances hearing on the application pursuant to
Application: R & D Systems, Inc. 21 CFR 1301.43 on or before August 30,
Demetra Ashley,
2017.
Acting Assistant Administrator. ACTION: Notice of application.
[FR Doc. 2017–16060 Filed 7–28–17; 8:45 am] ADDRESSES: Written comments should
DATES: Registered bulk manufacturers of be sent to: Drug Enforcement
BILLING CODE 4410–09–P
the affected basic classes, and Administration, Attention: DEA Federal
applicants therefore, may file written Register Representative/DRW, 8701
VerDate Sep<11>2014 17:38 Jul 28, 2017 Jkt 241001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 E:\FR\FM\31JYN1.SGM 31JYN1](https://thefederalregister.org/doc/82_FR_35691/page/1.svg)
![Federal Register / Vol. 82, No. 145 / Monday, July 31, 2017 / Notices 35547
Morrissette Drive, Springfield, Virginia SUPPLEMENTARY INFORMATION: The revocation of registration) has been
22152. All requests for hearing must be Attorney General has delegated his redelegated to the Assistant
sent to: Drug Enforcement authority under the Controlled Administrator of the DEA Diversion
Administration, Attn: Administrator, Substances Act to the Administrator of Control Division (‘‘Assistant
8701 Morrissette Drive, Springfield, the Drug Enforcement Administration Administrator’’) pursuant to section 7 of
Virginia 22152. All request for hearing (DEA), 28 CFR 0.100(b). Authority to 28 CFR part 0, appendix to subpart R.
should also be sent to: (1) Drug exercise all necessary functions with In accordance with 21 CFR
Enforcement Administration, Attn: respect to the promulgation and 1301.34(a), this is notice that on March
Hearing Clerk/LJ, 8701 Morrissette implementation of 21 CFR part 1301, 7, 2017, R & D Systems, Inc., Bio-
Drive, Springfield, Virginia 22152; and incident to the registration of Techne, 614 McKinley Place NE.,
(2) Drug Enforcement Administration, manufacturers, distributors, dispensers, Minneapolis, Minnesota 55413 applied
Attn: DEA Federal Register importers, and exporters of controlled to be registered as an importer of the
Representative/DRW, 8701 Morrissette substances (other than final orders in following basic classes of controlled
Drive, Springfield, Virginia 22152. connection with suspension, denial, or substances:
Controlled substance Drug code Schedule
Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... 1248 I
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .............................................................................. 7118 I
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ................................................................ 7297 I
Marihuana ........................................................................................................................................................................ 7360 I
Tetrahydrocannabinols .................................................................................................................................................... 7370 I
4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................. 7391 I
3,4-Methylenedioxymethamphetamine ............................................................................................................................ 7405 I
Dimethyltryptamine .......................................................................................................................................................... 7435 I
Psilocyn ........................................................................................................................................................................... 7438 I
Pentobarbital .................................................................................................................................................................... 2270 II
Phencyclidine ................................................................................................................................................................... 7471 II
Cocaine ............................................................................................................................................................................ 9041 II
The company plans to import bulk applicants therefore, may file written material are not appropriate. 72 FR
active pharmaceutical controlled comments on or objections to the 3417, (January 25, 2007).
substances for distribution to its issuance of the proposed registration in SUPPLEMENTARY INFORMATION: The
customers for analytical purposes. accordance with 21 CFR 1301.34(a) on Attorney General has delegated his
In reference to drug codes 7360 and or before August 30, 2017. Such persons authority under the Controlled
7370, the company plans to import a may also file a written request for a Substances Act to the Administrator of
synthetic cannabidiol and a synthetic hearing on the application pursuant to the Drug Enforcement Administration
tetrahydrocannabinol. No other activity 21 CFR 1301.43 on or before August 30, (DEA), 28 CFR 0.100(b). Authority to
for these drug codes is authorized for 2017. exercise all necessary functions with
this registration. respect to the promulgation and
ADDRESSES: Written comments should
Dated: July 24, 2017. implementation of 21 CFR part 1301,
be sent to: Drug Enforcement incident to the registration of
Demetra Ashley,
Administration, Attention: DEA Federal manufacturers, distributors, dispensers,
Acting Assistant Administrator. Register Representative/DRW, 8701
[FR Doc. 2017–16064 Filed 7–28–17; 8:45 am]
importers, and exporters of controlled
Morrissette Drive, Springfield, Virginia substances (other than final orders in
BILLING CODE 4410–09–P 22152. All requests for hearing must be connection with suspension, denial, or
sent to: Drug Enforcement revocation of registration) has been
Administration, Attn: Administrator, redelegated to the Assistant
DEPARTMENT OF JUSTICE
8701 Morrissette Drive, Springfield, Administrator of the DEA Diversion
Drug Enforcement Administration Virginia 22152. All request for hearing Control Division (‘‘Assistant
should also be sent to: (1) Drug Administrator’’) pursuant to section 7 of
[Docket No. DEA–392] Enforcement Administration, Attn: 28 CFR part 0, appendix of subpart R.
Importer of Controlled Substances Hearing Clerk/LJ, 8701 Morrissette In accordance with 21 CFR
Application: Sigma-Aldrich Drive, Springfield, Virginia 22152; and 1301.34(a), this is notice that on January
International GMBH (2) Drug Enforcement Administration, 19, 2016, Sigma-Aldrich International
Attn: DEA Federal Register GMBH, Sigma Aldrich Co. LLC, 3500
ACTION: Notice of application. Representative/DRW, 8701 Morrissette Dekalb Street, Saint Louis, Missouri
Drive, Springfield, Virginia 22152. 63118 applied to be registered as an
DATES: Registered bulk manufacturers of Comments and requests for hearings on importer of the following basic classes
the affected basic classes, and applications to import narcotic raw of controlled substances:
sradovich on DSKBCFCHB2PROD with NOTICES
Controlled substance Drug code Schedule
Cathinone ........................................................................................................................................................................ 1235 I
Methcathinone ................................................................................................................................................................. 1237 I
Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... 1248 I
N-Ethylamphetamine ....................................................................................................................................................... 1475 I
Aminorex .......................................................................................................................................................................... 1585 I
Gamma Hydroxybutyric Acid ........................................................................................................................................... 2010 I
VerDate Sep<11>2014 17:38 Jul 28, 2017 Jkt 241001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\31JYN1.SGM 31JYN1](https://thefederalregister.org/doc/82_FR_35691/page/2.svg)
Document Created: 2017-07-29 00:21:29
Document Modified: 2017-07-29 00:21:29
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before August 30, 2017. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before August 30, 2017. | |
| FR Citation | 82 FR 35546 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR